Tag:
Acute Myeloid Leukemia
Latest Headlines
Latest Headlines
Stemline bets $50M IPO on a pair of cancer stem cell treatments
New York-based Stemline Therapeutics is making a bid to go public and raise $50 million to help fund its mid-stage work on a pair of cancer stem cell treatments.
Ambit bounces back from dropped IPO with $30M round
A day after word that Ambit Biosciences had dropped plans for an $86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $30 million equity
